flow trial semaglutide chronic kidney disease results 2024 could be 'practice changing' for adults with diabetes, CKD EARLY TAVR in asymptomatic patients

#glp1 #yerbamate #superfood #healthyenergy #weightloss

As someone on a GLP-1 journey, finding delicious, supportive options is key

Find out if GLP-1 drugs is covered by Aetna, typical copay ranges, prior-auth rules, and affordable alternatives

Glucagon-like peptide-1(7-36)amide (GLP-1) is a 30-residue peptide hormone released from intestinal L cells following nutrient consumption

Common nutritional concerns associated with GLP-1 therapy may include: Reduced appetite and inadequate nutrient intake Loss of lean muscle mass during rapid weight reduction Nausea, digestive discomfort, and poor food tolerance Fatigue and reduced energy levels Micronutrient deficiencies over long-term use Increased nutritional needs in patients with complex clinical conditions Effective GLP-1 treatment requires more than medication alone